New antibody aims to clean heart of toxic protein clumps
NCT ID NCT07448623
First seen Mar 10, 2026 · Last updated Apr 24, 2026 · Updated 9 times
Summary
This early-stage study tests a new medicine called coramitug in 14 people with ATTR-CM, a heart condition caused by abnormal protein deposits. The drug is designed to bind to and help remove these deposits from the heart. Researchers will use special PET/CT scans to see how the drug travels in the body and whether it can clear the protein buildup. The study also checks for safety and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON - location Groningen
RECRUITINGGroningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.